Therapeutic Effect of Back-shu Point Catgut Embedding in Spleen-stomach Deficiency Type I and II Myasthenia Gravis

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Diagnosed with Myasthenia Gravis based on the diagnostic criteria of Practical internal science (Peoples Medical Publishing House The 15th edition)and patients with MG belonging to the the modifed Osseman III type;
•2. Diagnosed with Chinese medical diagnosis of flaccidity fitting to the differentiation standard of spleen-stomach deficiency type;
•3. Aged 18 to 75-year-old;
•4. Sign informed consent.

•1. Osseman III, IV, V;
•2. Familial MG, congenital myasthenic syndrome and drug (D-penicillamine, interferon induced by MG, etc.);
•3. Patients who were nursing or pregnant;
•4. Patients who had comorbid diseases such as cerebrovascular diseases, renal insufficiency, hematopoietic system diseases, and psychiatric diseases;
•5. Patients who has contraindications for embedding;
•6. Allergies (allergic to more than 2 kinds of food or medicine);
•7. The last 3 months participated in other clinical trials of drugs.

发起方

The First Affiliated Hospital of Guangzhou University of Chinese Medicine